Reiley Pharmaceuticals, Inc.

Pharmaceutical company · San Francisco, California, United States

Reiley Pharmaceuticals, Inc. is a pharmaceutical company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $97,655 sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Reiley Pharmaceuticals at a glance

Typepharmaceutical company

HeadquartersSan Francisco, California, United States

Earliest incorporation on record2014

SEC CIK1616308

What does Reiley Pharmaceuticals do?

Private fundraising reported to the SEC

8 Form D notices; the most recent reported $97,655 sold (2024).

Frequently asked questions about Reiley Pharmaceuticals

Where is Reiley Pharmaceuticals headquartered?

Reiley Pharmaceuticals, Inc. is headquartered in San Francisco, California, United States.

What does Reiley Pharmaceuticals do?

Reiley Pharmaceuticals, Inc. is a pharmaceutical company.

When was Reiley Pharmaceuticals founded?

The earliest incorporation on record for Reiley Pharmaceuticals, Inc. is in 2014, according to public company registers.

Similar companies

Kyntra Bio, Inc.San Francisco, California, United States
Nektar TherapeuticsSan Francisco, California, United States
Olema Pharmaceuticals, Inc.San Francisco, California, United States
GT Biopharma, Inc.San Francisco, California, United States
Delpor, Inc.San Francisco, California, United States
Jaguar Health, Inc.San Francisco, California, United States
Silver Creek Pharmaceuticals, Inc.San Francisco, California, United States
Amarantus Bioscience Holdings, Inc.San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences